| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/16/2008 | EP1910323A1 Process for preparing 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
| 04/16/2008 | EP1910273A2 10-substituted tetracyclines and methods of use thereof |
| 04/16/2008 | EP1909797A2 Dipiperazinyl ketones and related analogues |
| 04/16/2008 | EP1414787B1 New derivatives of substituted anilines with herbicidal activity |
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101161645A Urea derivatives as well as preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358374 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358358 includes (1) beta -(10-phenothiazyl)propoxy phosphonic acid; (2) beta -(10-phenothiazyl)propyl-phosphonic acid; and (3) beta -(10-phenothiazyl)propionate phosphonic acid; p-type redox promoters and redox chromophores |
| 04/15/2008 | US7358262 Using transgenic tumor cells as models for antitumor agent efficacy; tissue targeted therapy and antiproliferative agents |
| 04/15/2008 | US7358251 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents |
| 04/15/2008 | US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases |
| 04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
| 04/15/2008 | CA2213693C Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
| 04/10/2008 | WO2008040934A1 Hdac inhibitors |
| 04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080085891 Asthma and allergic inflammation modulators |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160297A 2-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators |
| 04/09/2008 | CN101157668A Substituted cinnamic acid nitrogen-containing derivative having tumor cytotoxic activity |
| 04/09/2008 | CN101157667A Morpholine quaternary ammonium salt ion liquid and preparation method thereof |
| 04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 04/08/2008 | US7355084 protonation of aromatic compounds in the presence of hydrogenation catalysts on supports; dearomatization; catalysis |
| 04/08/2008 | US7355045 Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof |
| 04/08/2008 | US7354942 Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 04/08/2008 | CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 04/03/2008 | WO2008040000A2 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039999A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008039794A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | WO2008037590A1 Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water |
| 04/03/2008 | WO2008037589A1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 04/03/2008 | WO2008037587A1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 04/03/2008 | US20080081856 Process for the preparation of polyphosphates of organic bases |
| 04/03/2008 | US20080081813 Lipid Lowering Biphenylcarboxamides |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/03/2008 | DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 04/03/2008 | CA2664365A1 Soluble epoxide hydrolase inhibitors |
| 04/03/2008 | CA2664364A1 Soluble epoxide hydrolase inhibitors |
| 04/02/2008 | EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same |
| 04/02/2008 | EP1904468A2 Parp modulators and treatment of cancer |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN101155793A Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 04/02/2008 | CN100378086C Novel piperazine derivatives and their use as synthesis intermediates |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351824 Intermediates for oxazolidinone antibacterials; N-[3-Chloro-2-(R)-hydroxypropyl]-3-fluoro-4-morpholinyl aniline |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/01/2008 | US7351742 Sulfonamide derivatives for the treatment of diseases |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
| 04/01/2008 | CA2332713C Hydroxamic acid derivatives as antibacterials |
| 03/27/2008 | WO2008035808A1 Process for production of highly pure quaternary ammonium salt |
| 03/27/2008 | WO2008016884A3 Soluble epoxide hydrolase inhibitors |
| 03/27/2008 | US20080076777 Piperazine Derivatives and Their Use in Controlling Pests |
| 03/27/2008 | US20080076769 Norvaline Derivative and Method for Preparation Thereof |
| 03/27/2008 | US20080076763 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol for treating cancer and arthritis |
| 03/27/2008 | US20080076762 Novel 4-Aminopiperidine Derivatives |
| 03/27/2008 | US20080074045 Organic electroluminescence device |
| 03/27/2008 | US20080072793 Includes an anti-slip compound for use on snow- or ice-covered surfaces, and to a related fertilizer compound for improving plant growth |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1902004A2 Onium-alkylsulfonate production method |
| 03/26/2008 | EP1901746A2 4-fluoro-piperidine t-type calcium channel antagonists |
| 03/26/2008 | EP1366015A4 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN100377004C Image forming material and ammonium compound |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348331 such as 6-(2,4-difluoro-phenoxy)-2-((S)-(+)-2-hydroxy-1-methyl-ethylamino)-8-((S)-2-hydroxy-propyl)-8H-pyrido[2,3-d]pyrimidin-7-one, used for treating p38 map kinase mediated disorders such as arthritis, Alzheimer's disease, gastrointestinal or respiratory system disorders |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008032814A1 Aspirin-containing pharmaceutical agent |
| 03/20/2008 | WO2008031157A1 Acetylenic compounds |
| 03/20/2008 | WO2008015137A3 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 03/20/2008 | WO2007147163A3 Compositions comprising carotenoid analogs or derivatives and methods for synthesis |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007072092A8 New phenanthridine derivatives as bradykinin antagonists |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070894 Anticancer agents; PLK1 inhibitors; PLK=polo-like kinase; imidazo(1,2-a)pyridines such as 5-bromo-4-[8-(difluoromethyl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-1-phenylethyl]-2-pyrimidinamine |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080069735 Gelling agent or a precursor to a gelling agent, a microsphere immobilized on a substrate, containing a yellow azo-methine dye; protein microarray; less costly and easier to prepare than those previously disclosed |
| 03/20/2008 | CA2663132A1 Acetylenic compounds |
| 03/19/2008 | EP1900723A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 03/19/2008 | EP1899310A1 Stereoselective hydrogenation process for preparing cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-2-methoxy-5,6,7,8-tetrahydronaphthalene hydrochloride |
| 03/19/2008 | EP1899302A1 Phenoxy acetic acids as ppar delta activators |
| 03/19/2008 | EP1899295A2 Prostaglandin derivatives |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | EP1899289A1 Method for producing aryl amines, aryl ethers and aryl thioethers |